BiotechTube

Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine

Phase 1Active
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pediatric Solid Tumor

Conditions

Pediatric Solid Tumor

Trial Timeline

Oct 25, 2022 → Jun 1, 2025

NCT ID
NCT05620862

About Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine

Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine is a phase 1 stage product being developed by Sun Pharmaceutical for Pediatric Solid Tumor. The current trial status is active. This product is registered under clinical trial identifier NCT05620862. Target conditions include Pediatric Solid Tumor.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05620862Phase 1Active

Competing Products

20 competing products in Pediatric Solid Tumor

See all competitors
ProductCompanyStageHype Score
RamucirumabEli LillyPhase 1
33
erlotinib + etoposideAstellas PharmaPhase 2
52
Perampanel Oral Suspension + Perampanel TabletEisaiPhase 2
52
Eribulin MesylateEisaiPhase 1
33
Decitabine + DecitabineEisaiPhase 2
52
Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once dailySumitomo PharmaPhase 1
33
Remimazolam Tosilate for injection + Propofol InjectionJiangsu Hengrui MedicinePhase 2/3
65
Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or LinezolidAstraZenecaPhase 2/3
65
candsartan cilexetilAstraZenecaPhase 3
77
Durvalumab / Tremelimumab Combination TherapyAstraZenecaPhase 1/2
41
Rotavirus VaccineMerckPre-clinical
23
basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroidsNovartisPhase 3
77
VAL489 + VAL489 matching placeboNovartisPhase 3
77
LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696NovartisPhase 2/3
65
EverolimusNovartisPhase 2
52
Corticosteroids + Cyclosporine + mycophenolate mofetilRochePhase 2
52
Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3
77
Blinatumomab for InjectionAmgenPhase 1
32
EtanerceptAmgenPhase 3
76
DenosumabAmgenPhase 3
76

Other Products from Sun Pharmaceutical

Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85